Chris Ogden
Director of Finance/CFO chez CYTOMX THERAPEUTICS, INC.
Fortune : 186 795 $ au 31/03/2024
Profil
Chris Ogden is currently the Chief Financial & Accounting Officer at CytomX Therapeutics, Inc. He previously worked as the Chief Financial Officer-Diabetes Division at Eli Lilly & Co. and as the Chief Financial Officer & Treasurer at Lilly del Caribe, Inc. Mr. Ogden completed his undergraduate degree at Wabash College and holds an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/03/2024 | 85 686 ( 0,13% ) | 186 795 $ | 31/03/2024 |
Postes actifs de Chris Ogden
| Sociétés | Poste | Début |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Director of Finance/CFO | 21/09/2022 |
Anciens postes connus de Chris Ogden
| Sociétés | Poste | Fin |
|---|---|---|
Lilly del Caribe, Inc.
 Lilly del Caribe, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly del Caribe, Inc. is a Puerto Rican pharmaceutical manufacturing company. The private company is based in Mayagüez, Puerto Rico. | Director of Finance/CFO | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Formation de Chris Ogden
| Wabash College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Lilly del Caribe, Inc.
Lilly del Caribe, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly del Caribe, Inc. is a Puerto Rican pharmaceutical manufacturing company. The private company is based in Mayagüez, Puerto Rico. | Health Technology |
